Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × repotrectinib × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Neoplasm Metastasis 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Radiosurgery 11 Magnetic Resonance Spectroscopy 8 Temozolomide 6 Bevacizumab 6 Specimen Handling 5 trastuzumab deruxtecan 4 pembrolizumab 4 Radiotherapy 4 Cyclophosphamide 4 Biopsy 4 abemaciclib 3 Nivolumab 3 entrectinib 2 Trastuzumab 2 Surveys and Questionnaires 2 Surgical Procedures, Operative 2 Sirolimus 2 Receptors, Interleukin-8B 2 Mental Status and Dementia Tests 2 Ipilimumab 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Dexamethasone 2 Adrenal Cortex Hormones 2 trastuzumab biosimilar HLX02 1 temsirolimus 1 ribociclib 1 repotrectinib 1 regorafenib 1 pertuzumab 1 patritumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06315010 2026-02-25

REPOSE

MedSIR

Phase 2 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡